Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 17;10(10):CD006226.
doi: 10.1002/14651858.CD006226.pub3.

Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS

Supat Sinawat  1 , Pranom Buppasiri, Pisake Lumbiganon, Porjai Pattanittum
Affiliations

Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS

Supat Sinawat et al. Cochrane Database Syst Rev. .

Abstract

Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive-aged women. Apart from infertility, women with PCOS often have other endocrine disorders, including insulin resistance, hyperinsulinaemia and hyperandrogenism. Metformin,combined with clomiphene citrate (CC), has been shown to be more effective in ovulation induction when compared with clomiphene citrate alone. The optimal duration for metformin pretreatment before initiation of clomiphene citrate, however, is unknown.

Objectives: To determine the effectiveness of short-course (less than four weeks) metformin plus CC versus long-course (four weeks or more) metformin plus CC with regard to ovulation and achievement of pregnancy in infertile women with PCOS.

Search methods: We searched the Cochrane Menstrual Disorders and Subfertility Group Trials Register, the Cochrane Central Register of Controlled Trials, MEDLINE, CINAHL, EMBASE and PsycINFO (all from inception to 1 February 2012).

Selection criteria: Randomised controlled trials comparing short-course (less than four weeks) metformin plus CC versus long-course (four weeks or more) metformin plus CC for ovulation or achievement of pregnancy in infertile women with PCOS.

Data collection and analysis: No trials were found that met the selection criteria.

Main results: No randomised controlled trials were identified.

Authors' conclusions: There are insufficient data to determine whether short-course metformin pretreatment is as effective as the conventional long-course metformin pretreatment before initiation of clomiphene citrate for ovulation induction in infertile women with PCOS. A well-designed randomised controlled trial is needed to answer this important clinical question.

PubMed Disclaimer

Conflict of interest statement

None known

Update of

References

Additional references

Barbieri 1986
    1. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 1986;62:904‐10. - PubMed
Dale 1992
    1. Dale PO, Tanbo T, Vaaler S, Abyholm T. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of the two distinct populations. Fertility and Sterility 1992;58:487‐91. - PubMed
ESHRE/ASRM 2003
    1. The Rotterdam ESHRE/ASRM‐Sponsored PCOS Concensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome. Fertility and Sterility 2004;81:19‐25. - PubMed
Franks 1995
    1. Franks S. Polycystic ovary syndrome. New England Journal of Medicine 1995;333:853‐61. - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. British Medical Journal 2003;327:557‐60. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hull 1987
    1. Hull MG. Epidemiology of infertility and polycystic ovarian diseases: endocrinological and demographic studies. Gynecological Endocrinology 1987;1:235‐45. - PubMed
Hwu 2005
    1. Hwu YM, Lin SY, Huang WY, Lin MH, Lee RK. Ultra‐short metformin pretreatment for clomiphene citrate‐resistant polycyctic ovary syndrome. International Journal of Gynaecology and Obstetrics 2005;90:39‐43. - PubMed
Kashyap 2004
    1. Kashyap S, Wells GA, Rosenwaks Z. Insulin‐sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Human Reproduction 2004;19:2474‐83. - PubMed
Khorram 2006
    1. Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L. Two weeks of metformin improves clomiphene citrate‐induced ovulation and metabolic profiles in women with polycyctic ovary syndrome. Fertility & Sterility 2006;85:1448‐51. - PubMed
Kim 2000
    1. Kim LH, Taylor AE, Barbieri RL. Insulin sensitizers and polycystic ovary syndrome: can a diabetes medication treat infertility?. Fertility and Sterility 2000;73:1097‐8. - PubMed
Lobo 1982
    1. Lobo RA, Gysler M, March CM, Goebelsmann U, Mishell DR Jr. Clinical and laboratory predictors of clomiphene response. Fertility and Sterility 1982;37:168‐74. - PubMed
Lord 2004
    1. Lord JM, Flight IH, Norman RJ. Insulin‐sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D‐chiro‐inositol) for polycystic ovary syndrome (Cochrane Review). Cochrane Database of Systematic Reviews 2004, Issue 2. - PubMed
Moll 2007
    1. Moll E, Veen F, Wely M. The role of metformin in polycystic ovary syndrome: a systematic review. Human Reproduction Updates Sep 1, 2007 [e‐pub ahead of print].. - PubMed
Nakamura 1997
    1. Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H. Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertility and Sterility 1997;67:256‐60. - PubMed
Nestler 1998a
    1. Nestler JE, Jakubowicz DJ, Vargas AF, Brick C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. Journal of Clinical Endocrinology and Metabolism 1998;83:2001‐5. - PubMed
Nestler 1998b
    1. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene‐induced ovulation in the polycystic ovary syndrome. New England Journal of Medicine 1998;338:1876‐80. - PubMed
Pirwany 1999
    1. Pirwany IR, Yates RW, Cameron IT, Fleming R. Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea. Human Reproduction 1999;14:2963‐8. - PubMed
Polson 1988
    1. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries‐a common finding in normal women. Lancet 1988;1:870‐2. - PubMed
Randall 1991
    1. Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertility and Sterility 1991;56:465‐8. - PubMed
Vandermolen 2001
    1. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertility and Sterility 2001;75:310‐5. - PubMed
Velazquez 1994
    1. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994;43:647‐54. - PubMed

Publication types

MeSH terms